- Home
- LMND vs MLTX Comparison
LMND vs MLTX Comparison
Compare LMND & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMND
- MLTX
- Stock Information
- Founded
- LMND 2015
- MLTX 2021
- Country
- LMND United States
- MLTX Switzerland
- Employees
- LMND N/A
- MLTX N/A
- Industry
- LMND Property-Casualty Insurers
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- LMND Finance
- MLTX Health Care
- Exchange
- LMND Nasdaq
- MLTX Nasdaq
- Market Cap
- LMND 2.0B
- MLTX 2.3B
- IPO Year
- LMND 2020
- MLTX N/A
- Fundamental
- Price
- LMND $26.78
- MLTX $38.33
- Analyst Decision
- LMND Hold
- MLTX Strong Buy
- Analyst Count
- LMND 9
- MLTX 8
- Target Price
- LMND $34.44
- MLTX $80.50
- AVG Volume (30 Days)
- LMND 1.8M
- MLTX 489.2K
- Earning Date
- LMND 04-29-2025
- MLTX 05-06-2025
- Dividend Yield
- LMND N/A
- MLTX N/A
- EPS Growth
- LMND N/A
- MLTX N/A
- EPS
- LMND N/A
- MLTX N/A
- Revenue
- LMND $526,500,000.00
- MLTX N/A
- Revenue This Year
- LMND $27.59
- MLTX $103.42
- Revenue Next Year
- LMND $32.79
- MLTX N/A
- P/E Ratio
- LMND N/A
- MLTX N/A
- Revenue Growth
- LMND 22.50
- MLTX N/A
- 52 Week Low
- LMND $14.03
- MLTX $31.42
- 52 Week High
- LMND $53.85
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- LMND 39.48
- MLTX 51.82
- Support Level
- LMND $26.08
- MLTX $31.90
- Resistance Level
- LMND $28.20
- MLTX $37.73
- Average True Range (ATR)
- LMND 2.58
- MLTX 2.99
- MACD
- LMND -0.23
- MLTX 0.29
- Stochastic Oscillator
- LMND 29.21
- MLTX 74.53
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.